Upcoming earnings
Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
About RGBOQ
ReGen Biologics, Inc. provides decision support information systems and consulting services to the health care industry. It offers outcomes-based products and services. The company's technology focuses on guided tissue generation. ReGen Biologics was founded by Shu-Tung Li on September 1, 1987 and is headquartered in Hackensack, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RGBOQ is 0.000001 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RGBOQ stocks are traded under the ticker RGBOQ.
RGBOQ is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
No, RGBOQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RGBOQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RGBOQ stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RGBOQ technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RGBOQ stock shows the strong sell signal. See more of RGBOQ technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.